Skip to main content
. 2022 Dec 6;17(1):130–138. doi: 10.5009/gnl220041

Fig. 1.

Fig. 1

Prevalence of NAFLD and liver fibrosis according to sarcopenic obesity status. (A) NAFLD according to sarcopenic obesity status. (B) Liver fibrosis according to sarcopenic obesity status.

NAFLD, nonalcoholic fatty liver disease; CAP, controlled attenuation parameter. *The prevalence of NAFLD and liver fibrosis based on ultrasound showed a statistically significant difference when compared with optimal (p<0.01); The prevalence of NAFLD based on the CAP score also showed a statistically significant difference when compared with optimal (p<0.01).